The largest database of trusted experimental protocols

Ni2 nta column

Manufactured by Qiagen
Sourced in United States, Germany

The Ni2+-NTA column is a chromatography column used for the purification of recombinant proteins containing a histidine-tag. The column matrix is coated with nickel ions (Ni2+) which bind to the histidine-tag on the target protein, allowing it to be separated from other cellular components during the purification process.

Automatically generated - may contain errors

28 protocols using ni2 nta column

1

Purification of MsVps4ΔMIT Protein from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The E. coli C41(DE3) strain was used as the host for protein expression. The cells were grown in lysogeny broth (LB) medium supplemented with ampicillin (100 μg ml−1) to an absorbance of ∼0.8 and expression was induced overnight at 20 °C by addition of 0.1 mM isopropyl-β-D-thiogalactopyranoside. The cells were pelleted by centrifugation (5,000g, 20 min), resuspended in lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10 mM imidazole and Complete Protease Inhibitor (Roche Diagnostics)), then disrupted by sonication. After centrifugation (20,000 r.p.m., 30 min, 4 °C), the bacterial lysate was applied onto a Ni2+−NTA column (Qiagen) for affinity purification. After extensive washing (50 mM Tris pH 8.0, 150 mM NaCl and 20 mM imidazole), the protein was eluted in presence of 300 mM imidazole. The fractions containing MsVps4ΔMIT were pooled and incubated overnight at room temperature with TEV (0.2 mg per 10 mg of protein) and dialysed against 25 mM HEPES, 150 mM NaCl and 10 mM imidazole. The TEV protease and uncleaved protein were removed by passing the solution through Ni2+-NTA column (Qiagen) and collecting the unbound protein. Cleaved MsVps4ΔMIT was concentrated to 80–150 μM using an Amicon 400 concentrator with 10-kDa cutoff membrane and purified by Superose 6 SEC on an ÄKTA FPLC system (GE Healthcare) in a buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl and 0.5 mM dithiothreitol.
+ Open protocol
+ Expand
2

Production and Purification of 6xHis-CHLH Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 6xHis-full-length CHLH protein was produced exactly as previously described (Wu et al., 2009 (link)). Briefly, cDNA encoding full-length CHLH was amplified by PCR using primers CHLH-Z1-F and CHLH-Z1-R. The PCR product was digested with EcoRI and SalI and then cloned into pET48b(+) at the EcoRI and SalI sites. The recombinant CHLH protein was expressed in E. coli Rosetta gami2 (DE3) (Novagen) and purified on a Ni2+-NTA column, as described in the manual provided by the manufacturer (Qiagen). Antiserum against 6xHis-full-length CHLH was raised by immunizing rabbits according to a standard protocol (Kiwa Laboratory Animals Co., Ltd). The primer sequences are listed in the Supplementary Table 1.
+ Open protocol
+ Expand
3

Recombinant CYP158A3 Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification of CYP158A3 were carried out as previously described, with some modifications (Lim et al., 2012 (link); Park et al., 2014 (link)). Briefly, Escherichia coli DH5α cells transformed with pCW (CYP158A3) and pGroEL/ES vectors were inoculated in Luria-Bertani (LB) broth containing 50 μg/mL ampicillin and 20 μg/mL kanamycin; cells were then pre-cultured overnight at 37°C. LB cultures were then seeded into 500 mL of Terrific broth (TB) expression medium containing 50 μg/mL ampicillin (1:100 dilution). The expression cultures were grown at 37°C, with shaking (220 rpm), until the optical density at 600 nm reached around 0.6 (Zhao et al., 2007 (link)). Following supplementation (0.5 mM 5-aminolevulinic acid, 1.0 mM IPTG, 1.0 mM thiamine, and trace elements), the cultures were incubated for a further 22–24 h at 28°C, with shaking (190 rpm). The bacterial soluble fractions containing CYP158A3 were isolated and prepared from the TB expression cultures. CYP158A3 was purified using a Ni2+-NTA column (Qiagen, Valencia, CA, USA), as described previously (Kim et al., 2005 (link); Park et al., 2011 (link)). The dialyzed fraction was further concentrated using an Amicon Ultra-15 centrifugal filter unit (Millipore, Billerica, MA, USA) and dialyzed against 10 mM potassium phosphate buffer containing 10% glycerol.
+ Open protocol
+ Expand
4

Heterologous Expression and Purification of CalR3

Check if the same lab product or an alternative is used in the 5 most similar protocols
A DNA fragment containing intact calR3 was amplified using KOD-plus DNA polymerase from S. chartreusis NRRL 3882 genomic DNA with primers 28aR3-F1 and 28aR3-F2. The obtained PCR fragment was double-digested using NdeI and EcoRI and then ligated with linearized vector pET28a(+) (Novagen) at the corresponding restriction sites to generate pET28a-calR3. After sequencing validation, pET28a-calR3 was introduced into E. coli BL21(DE3)/plysE (Stratagene) for protein over-expression. Cell growth, induction, and harvest conditions were performed as previously described (Wu et al., 2013 (link)). Collected cells were re-suspended in binding buffer (20 mM Tris-Cl, pH 8.0, 300 mM NaCl) and disrupted by ultrasonication. After centrifugation, the supernatant was loaded onto a Ni2+-NTA column (Qiagen, Germany) that had been pre-equilibrated with binding buffer. The elution condition was a linear-gradient of imidazole from 0 to 500 mM. The purified protein was desalted by a HisTrap desalination column with buffer C (100 mM Tris-HCl, pH 8.0) and measured using SDS-PAGE. Finally, the purified His6-tagged CalR3 protein was stored in stock buffer containing 10% glycerol at -80°C.
+ Open protocol
+ Expand
5

Purification of VopK Protein by Ni2+-NTA Chromatography

Check if the same lab product or an alternative is used in the 5 most similar protocols
VopK protein was purified by Ni2+-nitrilotriacetic acid (Ni2+-NTA) chromatography by following a published protocol [12 (link)]. The wild-type gene was cloned into the NdeI-BamHI site of the pET15b vector (Novagen) to generate an N-terminal His6-VopK fusion protein. The clone was confirmed by sequencing and transformed into E. coli BL21 (DE3). After induction with 0.4mM IPTG (isopropyl1-thio-β-D-galactopyranoside), VopK protein was purified through Qiagen Ni2+-NTA column. The purified protein was dialyzed overnight in a solution of buffer A containing 10mM Tris, pH 7.9, 100 mM KCl, 0.1mM EDTA, 0.1mM DTT, 5% glycerol. Protease assay was done essentially as described earlier [13 (link)].
+ Open protocol
+ Expand
6

cGAS Full-Length and Catalytic Domain Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cDNA of cGAS full length and catalytic domain were cloned into a modified pET-28a vector with an N-terminal Avi-His6-SUMO tag. Mouse cGAS catalytic domain (residues 142 – 507) was expressed in E.coli BL21 (DE3) with 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) induction overnight at 16°C and purified as described previously19 (link) . biotin-Avi-His6-SUMO human and mouse cGAS full length and catalytic domains (human cGAS domain residues 157 – 522) were expressed in E.coli BL21 (DE3) cells co-transformed with the plasmids coding for cGAS and the pBirAcm plasmid coding for BirA. Protein expression was induced with 0.4 mM IPTG in the presence of 5 μg/ml biotin (Sigma-Aldrich, B4501). The proteins were first purified using a Ni2+-NTA column (Qiagen) and were further purified over a Superdex200 column (GE Healthcare Life Sciences). biotin-Avi-His6-SUMO human and mouse cGAS full length and human cGAS catalytic domain were eluted with the buffer containing 20 mM Tris, 500 mM NaCl, pH 7.5. biotin-Avi-His6-SUMO mouse cGAS catalytic domain was eluted with the buffer containing 20 mM Tris, 150 mM NaCl, pH 7.5. All mutants were generated using a PCR-based technique with appropriate primers and confirmed by DNA sequencing. The cGAS mutant proteins were expressed and purified the same way as the wild-type cGAS.
+ Open protocol
+ Expand
7

Cloning and Purification of M. tuberculosis PanD

Check if the same lab product or an alternative is used in the 5 most similar protocols
The M. tuberculosis panD gene was PCR amplified from the genome of type strain H37Rv using the primers: panD F: 5′-TAT CCA TGG GCA TGT TAC GGA CGA TGC TGA AG-3′ and panD R: 5′-TAT CTC GAG TCC CAC ACC GAG CCG GGG GT-3′. The PCR product was digested with NcoI and XhoI and cloned into the pET28a plasmid vector digested with the same enzymes. The correct clones were confirmed by DNA sequencing. The PanD protein was purified as described.17 (link) Briefly, log phase E. coli strain BL21(DE3) containing pET28a-panD was induced with 0.5 mM IPTG at 37 °C for 4 h. The cells were harvested, resuspended in buffer A (10 mM Tris-HCl, pH 7.5, 150 mM NaCl), and lysed by sonication. The PanD protein was purified by using a Ni+2-NTA column (Qiagen, Valencia, CA, USA) and dialyzed against 10 mM Tris, pH 8.0. The protein fractions were eluted with imidazole and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
+ Open protocol
+ Expand
8

Purification of Ari-1 and KoiU2 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
pGEX-4T1_ari-1 and parkin (WT/RBR/OCD/OPEN/OPENA/OPENB) and pET28a_KoiU2 constructs were transformed into BL21-DE3 cells (NEB). Various Ari-1 constructs were expressed in LB, supplemented with 0.05mM IPTG and 0.2mM ZnCl2, for 22 hours in 18°C shaking. Cells were lysed with Bugbuster (Novagen). Proteins were purified following established protocols (Wenzel et al., 2011 (link)) with column packed with Gluthathione Sepharose 4B (Biorad, GE Healthcare). KoiU2 was expressed in LB supplemented with 0.05mM IPTG for 22 hours in 18°C. Proteins were purified using Ni2+-NTA column (Qiagen, Biorad) and eluted with 500mM imidazole. Proteins were subsequently dialyzed against 50mM Tris pH8.0, 200mM NaCl to remove imidazole.
+ Open protocol
+ Expand
9

Purification and Interaction of HSP90 and USP19

Check if the same lab product or an alternative is used in the 5 most similar protocols
The His-tagged HSP90 (in pET-28a) and GST-fused CS1 (residues 75–209) or CS2 (273–393) domain of USP19_b (in pGEX-4T-3) were expressed in E. coli BL21 (DE3) strain. The His-tagged HSP90 was purified through a Ni2+-NTA column (Qiagen), while GST-fused proteins were purified using the glutathione Sepharose 4B column (Amersham Bioscience). GST or GST-fused proteins were incubated with the glutathione Sepharose 4B beads in a PBS buffer (10 mM Na2HPO4, 140 mM NaCl, 2.7 mM KCl, 1.8 mM KH2PO4, pH 7.4), and the suspension was agitated at 4°C for 30 min. The beads were washed three times in the same buffer to remove any unbound protein. An equal molar amount of HSP90 was added, and the suspension was agitated at 4°C for about 2 hrs. After excessive washing, the beads were re-suspended in the sample buffer and subjected to SDS-PAGE followed by Coomassie staining.
+ Open protocol
+ Expand
10

Heterologous Expression of Echinacea Enzymes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length CDS of EpHTT, EpHQT, and EpHCT were amplified from Echinacea purpurea hairy root cDNA using primers listed in Supplementary Table 4 and cloned into the pDEST17 plasmid with 6 x His at the N-terminus53 (link). The recombinant plasmids were transformed into E. coli BL21(DE3) which was grown on LB solid medium (50 μg/mL ampicillin). Overnight cultures were transferred to 200 mL LB liquid medium containing antibiotics until the OD600 reached 0.5–1.0. Isopropyl β-D-1-thiogalactopyranoside was added to a final concentration of 0.4 mM, and the cultures were grown overnight at 16 °C with shaking at 200 rpm. Cells were harvested by centrifugation at 5,000 × g for 5 min.
Cells were resuspended in lysis buffer (25 mM Tris–HCl 8.0, 150 mM NaCl, 0.5 mM tris(2-carboxyethyl)phosphine). ATP (1 mM) and PMSF (1 mM) were also added. The cells were broken using a disruptor with 600 bar. After centrifugation at 20,000 × g at 4 °C for 30 min, the supernatant was collected. Protein was purified using a Ni2+-NTA column (Qiagen) according to the manufacturer’s instructions. Imidazole was removed using FPLC coupled with HiTrap Q HP column for purification of enzymes from crude extracts. The protein concentration was determined using a BCA kit (Sangon Biotech, China). Recombinant proteins were stored in PBS (pH7.0 with 10% glycerol) at -80 °C before use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!